Assesses mortality differences in Medicare beneficiaries with generalized myasthenia gravis, indicating potential health disparities.
To assess differences in mortality among Medicare beneficiaries with generalized myasthenia gravis (gMG) and without MG.
No takes yet. Share an insight, caveat, or question.
Jackson et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: